The factor V Leiden and the G20210A prothrombin gene mutations are rare in women with fetal death

Am J Reprod Immunol. 2005 Jul;54(1):1-4. doi: 10.1111/j.1600-0897.2005.00277.x.

Abstract

Problem: To determine if there is an association between two commonly inherited thrombophilias, the factor V Leiden and the G20210A prothrombin mutations, and fetal death.

Method of study: We used a case-control study design to compare the frequencies of these mutations in women with fetal death and controls. Fetal death was the intrauterine death of the conceptus > or =10 weeks gestation. Controls had one live birth, no miscarriages, and no fetal death. Results were compared using chi square analysis.

Results: One hundred and seventy-five cases and controls were identified. There were 4.6% of cases and 3.8% of controls heterozygous for the factor V Leiden mutation (NS), and 1.3% of cases and 1.7% of controls heterozygous for the prothrombin mutation (NS).

Conclusion: In our population, neither the factor V Leiden nor the G20210A prothrombin mutations are associated with fetal death. Further evidence is required before routine screening for these mutations can be recommended.

MeSH terms

  • Adolescent
  • Adult
  • Case-Control Studies
  • DNA Mutational Analysis
  • Factor V / genetics*
  • Female
  • Fetal Death / genetics*
  • Glycine / genetics*
  • Glycine / metabolism
  • Humans
  • Mutation / genetics*
  • Pregnancy
  • Prothrombin / genetics*

Substances

  • factor V Leiden
  • Factor V
  • Prothrombin
  • Glycine